Cagrilintide Starting Dose and Titration Unlike tirzepatide's gradual multi-step escalation, cagrilintide trials have typically employed a simpler titration approach: Typical Cagrilintide Escalation: Weeks 1-4: 0.6 mg weekly Weeks 5-8: 1.2 mg weekly Week 9 onward: 2.4 mg weekly (maintenance) This three-step approach allows for tolerance development while reaching the therapeutic dose more quickly than tirzepatide's six-step protocol
Treatment duration depends on your individual goals, response to therapy, and your provider assessment
Your provider may adjust aspirin dosing, recommend alternative pain management strategies, or increase monitoring frequency to catch any adverse interactions early
GLP-1 drugs such as semaglutide (Ozempic) and tirzepatide (Mounjaro) mimic the actions of the GLP-1 hormone
A tendency for improved nonalcoholic fatty liver disease (NAFLD) liver fat score in the SIRD group compared with the SIDD group in response to semaglutide was also observed (Extended Data Fig
In clinical trials, patients lost an average of 15% of their body weight